Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 217S · 10 late217 trades$54.77M
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
IBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
BBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K
BCYCBICYCLE THERAPEUTICS PLCOct 2 – Oct 56 insiders$63K| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 22 | Kumar MukulPRESIDENT, ENGINEERING |  PUBMPubMatic, Inc.Open-market sale · 10b5-1 plan | SELL | $134K 8,000 sh | Sep 18, 2026 |
| 22 | Feeley KevinCHIEF FINANCIAL OFFICER |  WGSGeneDx Holdings Corp.Open-market sale | SELL | $144K 1,470 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 22 | Wetterwald JulienChief Technology Officer | WLTHWEALTHFRONT CORP Open-market sale · 10b5-1 plan | SELL | $264K 26.1K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 22 | Stueland KatherineDirector, CHIEF EXECUTIVE OFFICER | WGSGeneDx Holdings Corp. Open-market sale | SELL | $14K 148 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 22 | Feeley KevinCHIEF FINANCIAL OFFICER | WGSGeneDx Holdings Corp. Open-market sale | SELL | $55K 586 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 22 | Mancini AnthonySee Remarks |  RVMDRevolution Medicines, Inc.Open-market sale · 10b5-1 plan | SELL | $348K 1,747 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 21 | Budur KumarCHIEF MEDICAL OFFICER |  HRMYHarmony Biosciences Holdings, Inc.Open-market sale | SELL | $34K 800 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 20 | Anders JackChief Financial Officer | RVMDRevolution Medicines, Inc. Open-market sale · 10b5-1 plan | SELL | $12K 61 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 20 | von Ahn LuisDirector, President & CEO, Co-Founder, 10% Owner |  DUOLDuolingo, Inc.Open-market sale · 10b5-1 plan | SELL | $155K 1,020 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 20 | Cislini JeffSVP & General Counsel | RVMDRevolution Medicines, Inc. Open-market sale · 10b5-1 plan | SELL | $10K 52 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 20 | Sandler Alan B.Chief Development Officer | RVMDRevolution Medicines, Inc. Open-market sale · 10b5-1 plan | SELL | $975 5 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 19 | Feeley KevinCHIEF FINANCIAL OFFICER | WGSGeneDx Holdings Corp. Open-market sale | SELL | $4,961 52 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 19 | Okupe OluyemiChief Financial Officer |  HIMSHims & Hers Health, Inc.Open-market sale · 10b5-1 plan | SELL | $355K 12.3K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 18 | Lo FrancisChief People Officer | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $3.01M 107.5K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 17 | Furner John R.Director, President & CEO |  WMTWalmart Inc.Open-market sale · 10b5-1 plan | SELL | $646K 6,045 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 17 | Furner John R.Director, President & CEO | WMTWalmart Inc. Open-market sale · 10b5-1 plan | SELL | $754K 7,080 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 16 | Lin LaurenCLO, CCO and Secretary | WLTHWEALTHFRONT CORP Open-market sale · 10b5-1 plan | SELL | $46K 4,574 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 16 | Polovin AndrewEVP, Chief Legal Officer |  TEMTempus AI, Inc.Open-market sale · 10b5-1 plan | SELL | $221K 2,951 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 16 | Mancini AnthonySee Remarks | RVMDRevolution Medicines, Inc. Open-market sale · 10b5-1 plan | SELL | $5,266 27 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 16 | Wang LingkeDirector, President |  LIFEEthos Technologies Inc.Open-market sale · 10b5-1 plan | SELL | $4.31M 110.6K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 14 | Sousa Mauad BrunoDirector | AUGOAura Minerals Inc. Open-market sale | SELL | $19K 606 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 14 | Sousa Mauad BrunoDirector | AUGOAura Minerals Inc. Open-market sale | SELL | $19K 200 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 14 | Sousa Mauad BrunoDirector | AUGOAura Minerals Inc. Open-market sale | SELL | $853 29 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 13 | Reynoso Jamie L.CEO, Medicare Advantage |  CLOVCLOVER HEALTH INVESTMENTS, CORP. /DEOpen-market sale · 10b5-1 plan | SELL | $8,760 1,921 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 13 | Fukushima RyanCEO, Data | TEMTempus AI, Inc. Open-market sale · 10b5-1 plan | SELL | $49K 700 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 12 | Zage George Raymond IIIDirector, 10% Owner |  GRNDGrindr Inc.Open-market sale · 10b5-1 plan | SELL | $2.56M 166.4K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 11 |  Sahin UgurChief Executive Officer, 10% Owner |  BNTXBioNTech SEOpen-market sale · 10b5-1 plan | SELL | $2.89M 30.0K sh | Sep 18, 2026 traded Sep 18, 2026 |
| 11 | Sahin UgurChief Executive Officer, 10% Owner | BNTXBioNTech SE Open-market sale · 10b5-1 plan | SELL | $3.35M 34.0K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 11 | Nicholas Christopher JamesExecutive Vice President | WMTWalmart Inc. Open-market sale · 10b5-1 plan | SELL | $160K 1,505 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 11 | Nicholas Christopher JamesExecutive Vice President | WMTWalmart Inc. Open-market sale · 10b5-1 plan | SELL | $149K 1,395 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 10 | Cummings MarthaDirector |  MQMarqeta, Inc.Open-market sale · 10b5-1 plan | SELL | $11K 713 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 9 | Wang LingkeDirector, President | LIFEEthos Technologies Inc. Open-market sale · 10b5-1 plan | SELL | $285K 7,431 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 9 | Colis Peter GeorgeDirector, CEO and Secretary | LIFEEthos Technologies Inc. Open-market sale · 10b5-1 plan | SELL | $822K 21.1K sh | Sep 18, 2026 traded Sep 17, 2026 |
| 9 | Colis Peter GeorgeDirector, CEO and Secretary | LIFEEthos Technologies Inc. Open-market sale · 10b5-1 plan | SELL | $850K 21.4K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 9 | Sullivan Christopher RyanChief Financial Officer |  AVTXAvalo Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $202K 12.4K sh | Sep 18, 2026 traded Sep 16, 2026 |
| 9 | Colis Peter GeorgeDirector, CEO and Secretary | LIFEEthos Technologies Inc. Open-market sale · 10b5-1 plan | SELL | $357K 9,648 sh | Sep 18, 2026 traded Sep 18, 2026 |
| 9 | Colis Peter GeorgeDirector, CEO and Secretary | LIFEEthos Technologies Inc. Open-market sale · 10b5-1 plan | SELL | $259K 7,190 sh | Sep 18, 2026 traded Sep 18, 2026 |
| 7 | Eisen Anthony MathewDirector |  XYZBlock, Inc.Open-market sale · 10b5-1 plan | SELL | $468K 6,000 sh | Sep 18, 2026 traded Sep 17, 2026 |
| 7 | Eisen Anthony MathewDirector | XYZBlock, Inc. Open-market sale · 10b5-1 plan | SELL | $470K 6,000 sh | Sep 18, 2026 traded Sep 16, 2026 |
| 7 | Eisen Anthony MathewDirector | XYZBlock, Inc. Open-market sale · 10b5-1 plan | SELL | $459K 6,000 sh | Sep 18, 2026 traded Sep 18, 2026 |